 |
7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one-2HCL |
|---|---|
| Trade Name | |
| Orphan Indication | Mantle cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-07 00:00:00 |
| Sponsor | Oncoceutics, Inc.;3624 Market Street, Suite 5E;Philadelphia, Pennsylvania, 19104 |
